SILREAL Blog

In today’s rapidly evolving healthcare landscape, launching a digital health product requires more than just innovation. It demands a comprehensive understanding of regulatory frameworks, market dynamics, and strategic execution. As senior executives steering global policy and market access, you must navigate complex international regulations while aligning your commercial strategy with real-world policy realities. This article provides a clear, actionable roadmap to develop

Entering the Chinese medtech market presents a unique set of challenges and opportunities for European companies. With its vast population, rapidly evolving healthcare infrastructure, and increasing demand for innovative medical technologies, China is a critical growth frontier. However, success requires more than just product innovation; it demands a deep understanding of regulatory frameworks, market dynamics, and strategic partnerships. In this article, I will share action

In the pharmaceutical and biotech industry, disruption is not new. The sector has been reshaped over the decades by breakthrough science, digital innovation and changing patient needs. However, today there is another force of change that is shaping the events: U.S policy and geopolitics. To European pharma and biotech leaders, American legislation is becoming the determinant of international rivalry. What is done in Washington does not remain in Washington, it permeates the s

The health-tech sector is evolving rapidly, driven by innovation and the urgent need for efficient healthcare solutions. As I explore this dynamic landscape, I see vast potential for strategic investments that can transform healthcare delivery and outcomes. The convergence of technology and healthcare opens doors to new business models, improved patient care, and scalable solutions. Understanding how to navigate this space is essential for those aiming to capitalize on its gr